{"id":562707,"date":"2026-08-13T20:00:00","date_gmt":"2026-08-13T18:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/expanded-possibilities-thanks-to-innovative-classes-of-active-ingredients\/"},"modified":"2026-08-20T14:46:04","modified_gmt":"2026-08-20T12:46:04","slug":"expanded-possibilities-thanks-to-innovative-classes-of-active-ingredients","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/expanded-possibilities-thanks-to-innovative-classes-of-active-ingredients\/","title":{"rendered":"Expanded Possibilities Thanks to Innovative Classes of Active Ingredients"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Myasthenic syndromes result from a disturbance in neuromuscular transmission. Although there is still no curative treatment for myasthenia gravis, the drug treatment options available today offer tailored therapeutic approaches aimed at sustainably improving the quality of life for those affected. In this context, in addition to disease activity, antibody status is also becoming increasingly relevant to treatment, for example, in the indication of C5 complement inhibitors or FcRn blockers.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fexpanded-possibilities-thanks-to-innovative-classes-of-active-ingredients%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Myasthenic syndromes result from a disturbance in neuromuscular transmission. Although there is still no curative treatment for myasthenia gravis, the drug treatment options available today offer tailored therapeutic approaches aimed&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fexpanded-possibilities-thanks-to-innovative-classes-of-active-ingredients%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":562711,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Myasthenia gravis: immunomodulatory therapies for long-term treatment  ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11548,11513,11297,11363,11423,11503],"tags":[99479,14227,40517,99487,46755,99490,99485,99494,67270,51650,99483,73072,99477,65494,22683,58931,24883,99481,99496,13389,99493,99495,99497,99492,99498,99488],"powerkit_post_featured":[],"class_list":["post-562707","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-congress-reports","category-general-internal-medicine","category-neurology","category-ophthalmology","category-studies","tag-acetylcholinesterase-inhibitor-2","tag-azathioprine","tag-b-cell-depletion","tag-complement-inhibitors","tag-eculizumab-en","tag-efgartigimod","tag-fcrn-modulators","tag-imaavy","tag-intravenous-immunoglobulins","tag-ivig-en","tag-mestinon","tag-myasthenia-gravis-en","tag-myasthenic-syndromes","tag-mycophenolate-mofetil-en","tag-oral-steroids","tag-plasmapheresis","tag-prednisone","tag-pyridostigmine","tag-ravulizumab","tag-rituximab-en","tag-rozanolixizumab","tag-soliris","tag-ultomiris","tag-vyvgart","tag-zilbrysq","tag-zilucoplan","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-09-01 21:29:45","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":562713,"slug":"des-possibilites-elargies-grace-a-des-classes-de-principes-actifs-innovants","post_title":"Des possibilit\u00e9s \u00e9largies gr\u00e2ce \u00e0 des classes de principes actifs innovants","href":"https:\/\/medizinonline.com\/fr\/des-possibilites-elargies-grace-a-des-classes-de-principes-actifs-innovants\/"},"it_IT":{"locale":"it_IT","id":562738,"slug":"maggiori-possibilita-grazie-a-classi-di-principi-attivi-innovativi","post_title":"Maggiori possibilit\u00e0 grazie a classi di principi attivi innovativi","href":"https:\/\/medizinonline.com\/it\/maggiori-possibilita-grazie-a-classi-di-principi-attivi-innovativi\/"},"pt_PT":{"locale":"pt_PT","id":562745,"slug":"possibilidades-alargadas-gracas-a-classes-inovadoras-de-principios-ativos","post_title":"Possibilidades alargadas gra\u00e7as a classes inovadoras de princ\u00edpios ativos","href":"https:\/\/medizinonline.com\/pt-pt\/possibilidades-alargadas-gracas-a-classes-inovadoras-de-principios-ativos\/"},"es_ES":{"locale":"es_ES","id":562754,"slug":"mayores-posibilidades-gracias-a-clases-innovadoras-de-principios-activos","post_title":"Mayores posibilidades gracias a clases innovadoras de principios activos","href":"https:\/\/medizinonline.com\/es\/mayores-posibilidades-gracias-a-clases-innovadoras-de-principios-activos\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/562707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=562707"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/562707\/revisions"}],"predecessor-version":[{"id":562712,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/562707\/revisions\/562712"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/562711"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=562707"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=562707"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=562707"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=562707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}